Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.

A S Jensen; L Idorn; C Thomsen; P von der Recke; J Mortensen; K E Sørensen; Ulf Thilén; E Nagy; K F Kofoed; S R Ostrowski; L Søndergaard

doi:10.1136/heartjnl-2015-307657

Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.

A S Jensen, L Idorn, C Thomsen, P von der Recke, J Mortensen, K E Sørensen, Ulf Thilén, E Nagy, K F Kofoed, S R Ostrowski, L Søndergaard

Cardiology

Research output: Contribution to journal › Article › peer-review

Abstract

Patients with cyanotic congenital heart disease (CCHD) have a high prevalence of thrombosis, the most frequently described locations being the cerebral and pulmonary vessels. The reported prevalence of both cerebral infarction and pulmonary thrombosis has been highly variable. The aim of this study was to examine the prevalence of both cerebral and pulmonary thrombosis in CCHD according to medical history and imaging. In addition, the role of known erythrocytosis and haemostatic abnormalities as risk factors was evaluated.

Original language	English
Pages (from-to)	1540-1546
Journal	Heart
Volume	101
Issue number	19
DOIs	https://doi.org/10.1136/heartjnl-2015-307657
Publication status	Published - 2015

Subject classification (UKÄ)

Cardiac and Cardiovascular Systems

Access to Document

10.1136/heartjnl-2015-307657

http://www.ncbi.nlm.nih.gov/pubmed/26048878?dopt=Abstract

Cite this

@article{78f37ff6ac8e4ef395b5b6f61c17a2a9,

title = "Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.",

abstract = "Patients with cyanotic congenital heart disease (CCHD) have a high prevalence of thrombosis, the most frequently described locations being the cerebral and pulmonary vessels. The reported prevalence of both cerebral infarction and pulmonary thrombosis has been highly variable. The aim of this study was to examine the prevalence of both cerebral and pulmonary thrombosis in CCHD according to medical history and imaging. In addition, the role of known erythrocytosis and haemostatic abnormalities as risk factors was evaluated.",

author = "Jensen, {A S} and L Idorn and C Thomsen and {von der Recke}, P and J Mortensen and S{\o}rensen, {K E} and Ulf Thil{\'e}n and E Nagy and Kofoed, {K F} and Ostrowski, {S R} and L S{\o}ndergaard",

year = "2015",

doi = "10.1136/heartjnl-2015-307657",

language = "English",

volume = "101",

pages = "1540--1546",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "19",

}

TY - JOUR

T1 - Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.

AU - Jensen, A S

AU - Idorn, L

AU - Thomsen, C

AU - von der Recke, P

AU - Mortensen, J

AU - Sørensen, K E

AU - Thilén, Ulf

AU - Nagy, E

AU - Kofoed, K F

AU - Ostrowski, S R

AU - Søndergaard, L

PY - 2015

Y1 - 2015

N2 - Patients with cyanotic congenital heart disease (CCHD) have a high prevalence of thrombosis, the most frequently described locations being the cerebral and pulmonary vessels. The reported prevalence of both cerebral infarction and pulmonary thrombosis has been highly variable. The aim of this study was to examine the prevalence of both cerebral and pulmonary thrombosis in CCHD according to medical history and imaging. In addition, the role of known erythrocytosis and haemostatic abnormalities as risk factors was evaluated.

AB - Patients with cyanotic congenital heart disease (CCHD) have a high prevalence of thrombosis, the most frequently described locations being the cerebral and pulmonary vessels. The reported prevalence of both cerebral infarction and pulmonary thrombosis has been highly variable. The aim of this study was to examine the prevalence of both cerebral and pulmonary thrombosis in CCHD according to medical history and imaging. In addition, the role of known erythrocytosis and haemostatic abnormalities as risk factors was evaluated.

U2 - 10.1136/heartjnl-2015-307657

DO - 10.1136/heartjnl-2015-307657

M3 - Article

C2 - 26048878

SN - 1355-6037

VL - 101

SP - 1540

EP - 1546

JO - Heart

JF - Heart

IS - 19

ER -

Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this